Status | Study |
Active, not recruiting |
Study Name: Impact of Adjuvant FOLFOX on Quality of Life and Sensory Neurotoxicity in Patients With Advanced Gastric Cancer Condition: Stomach Neoplasms Date: 2015-09-06 Interventions: Other: Quality of life assessment Quality of life and chemotherapy induced neurotoxicity evaluation |
Recruiting |
Study Name: Monosialoganglioside Preventing Neurotoxicity Induced by Albumin-bound Paclitaxel Chemotherapy in Lung Cancer Patients Condition: Neurotoxicity Date: 2015-07-11 Interventions: Drug: monosialoganglioside 40mg in the vein on day 1 - day 8 of each 21 days cycle. Number of Cycles: 2 |
Recruiting |
Study Name: To Study the Individual Variants of Chemotherapy-Induced Neurotoxicity Condition: Neurotoxicity Syndromes Date: 2015-06-09 Interventions: Other: Questionnaires EORTC CI |
Recruiting |
Study Name: Monosialotetrahexosylganglioside for Treatment of Oxaliplatin Induced Neurotoxicity in Gastrointestinal Cancer Condition: Neurotoxicity Date: 2015-05-03 Interventions: Drug: placebo |
Recruiting |
Study Name: Monosialotetrahexosylganglioside Sodium Injection for Prevention Neurotoxicity of mFOLFOX 6 in Advanced Gastric Cancer Condition: Gastric Cancer Date: 2013-12-01 Interventions: Drug: monosialotetrahexosylganglioside Sodium |
Recruiting |
Study Name: Monosialotetrahexosylganglioside Sodium Injection for Prevention Neurotoxicity of mFOLFOX 6 in mCRC Condition: Colorectal Cancer Date: 2013-11-24 Interventions: Drug: monosialotetrahexosylganglioside Sodium |
Recruiting |
Study Name: Monosialoganglioside(GM1) Preventing Neurotoxicity Induced by Cisplatin Contained Chemotherapy in NSCLC Patients Condition: Non-small Cell Lung Cancer Date: 2013-06-17 Interventions: Drug: Monosialoganglioside(GM1) |
Completed |
Study Name: Neurotoxicity Characterization Study of Nab-paclitaxel Versus Conventional Paclitaxel in Metastatic Breast Cancer Condition: Breast Cancer Date: 2012-12-14 Interventions: Drug: Paclitaxel 80 mg/m2 Pacl |
Terminated |
Study Name: Study to Assess Prevention of Oxaliplatin-induced Neurotoxicity Through Vitamin D Pathway Condition: Neurotoxicity Date: 2011-10-18 Interventions: Drug: Vitamin D3 Vitamin D3 will be administered at a dose of 2000 IU orally daily starting on day 1 of |
Withdrawn |
Study Name: A Trial of Glutamine to Prevent Oxaliplatin Neurotoxicity and a Pharmacokinetic Analysis of Oxaliplatin Condition: Colorectal Carcinoma Neoplasms, Colorectal Colorectal Canc Date: 2010-07-02 Interventions: Dietary Supplement: Glutamine Glutamine- During the first cycle of oxaliplatin based combination therapy |